Abstract
Of 51 patients with herpes simplex labialis, 50 had detectable interferon (IFN) in samples of lesion vesicle fluid. The median titer of vesicle fluid IFN was 8,200 U. and the range of values was 400 to 63,600 U. The amount of vesicle fluid IFN was correlated with lesion age (r = 0.32, P = 0.024) and vesicle fluid virus titer (r = 0.59, P = 0.00004), but not with the clinical severity of the disease. The presence of vesicle fluid IFN (1,500 to 28,600 U) in 15 lesions less than 12 h old emphasizes the need for early treatment in studies of antiviral agents for herpes simplex labialis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Green J. A., Yeh T. J., Overall J. C., Jr Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons. J Clin Microbiol. 1980 Sep;12(3):433–438. doi: 10.1128/jcm.12.3.433-438.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gresser I., Tovey M. G., Maury C., Bandu M. T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med. 1976 Nov 2;144(5):1316–1323. doi: 10.1084/jem.144.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guinan M. E., MacCalman J., Kern E. R., Overall J. C., Jr, Spruance S. L. Topical ether and herpes simplex labialis. JAMA. 1980 Mar 14;243(10):1059–1061. [PubMed] [Google Scholar]
- Kern E. R., Overall J. C., Jr, Glasgow L. A. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis. 1973 Sep;128(3):290–299. doi: 10.1093/infdis/128.3.290. [DOI] [PubMed] [Google Scholar]
- Overall J. C., Jr, Spruance S. L., Green J. A. Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis. J Infect Dis. 1981 Apr;143(4):543–547. doi: 10.1093/infdis/143.4.543. [DOI] [PubMed] [Google Scholar]
- Overall J. C., Jr, Yeh T. J., Kern E. R. Sensitivity of herpes simplex virus types 1 and 2 to three preparations of human interferon. J Infect Dis. 1980 Dec;142(6):943–943. doi: 10.1093/infdis/142.6.943. [DOI] [PubMed] [Google Scholar]
- Pazin G. J., Armstrong J. A., Lam M. T., Tarr G. C., Jannetta P. J., Ho M. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med. 1979 Aug 2;301(5):225–230. doi: 10.1056/NEJM197908023010501. [DOI] [PubMed] [Google Scholar]
- Spruance S. L., Crumpacker C. S., Haines H., Bader C., Mehr K., MacCalman J., Schnipper L. E., Klauber M. R., Overall J. C., Jr Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis. N Engl J Med. 1979 May 24;300(21):1180–1184. doi: 10.1056/NEJM197905243002103. [DOI] [PubMed] [Google Scholar]
- Spruance S. L., Krueger G. G., MacCalman J., Overall J. C., Jr, Klauber M. R. Treatment of recurrent herpes simplex labialis with levamisole. Antimicrob Agents Chemother. 1979 May;15(5):662–665. doi: 10.1128/aac.15.5.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spruance S. L., Overall J. C., Jr, Kern E. R., Krueger G. G., Pliam V., Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977 Jul 14;297(2):69–75. doi: 10.1056/NEJM197707142970201. [DOI] [PubMed] [Google Scholar]
- Stevens D. A., Merigan T. C. Interferon, antibody, and other host factors in herpes zoster. J Clin Invest. 1972 May;51(5):1170–1178. doi: 10.1172/JCI106910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zawatzky R., Hilfenhaus J., Marcucci F., Kirchner H. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol. 1981 Mar;53(Pt 1):31–38. doi: 10.1099/0022-1317-53-1-31. [DOI] [PubMed] [Google Scholar]